Gf Fund Management Co. Ltd. Larimar Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,583 shares of LRMR stock, worth $4,099. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,583
Previous 1,340
18.13%
Holding current value
$4,099
Previous $5.19 Million
34.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LRMR
# of Institutions
109Shares Held
64.5MCall Options Held
93.5KPut Options Held
68K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$55 Million1.16% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$15.7 Million0.27% of portfolio
-
Janus Henderson Group PLC London, X05.57MShares$14.4 Million0.01% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.78MShares$12.4 Million5.31% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$8.84 Million6.65% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $112M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...